163 related articles for article (PubMed ID: 19940985)
1. Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.
Molanaei H; Carrero JJ; Heimbürger O; Nordfors L; Lindholm B; Stenvinkel P; Odar-Cederlöf I; Bertilsson L
Eur J Clin Pharmacol; 2010 Mar; 66(3):269-73. PubMed ID: 19940985
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
3. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths.
Frost J; Løkken TN; Helland A; Nordrum IS; Slørdal L
Forensic Sci Int; 2016 May; 262():128-37. PubMed ID: 26986973
[TBL] [Abstract][Full Text] [Related]
4. The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects.
Wu X; Yuan L; Zuo J; Lv J; Guo T
Eur J Clin Pharmacol; 2014 Jan; 70(1):57-63. PubMed ID: 24077935
[TBL] [Abstract][Full Text] [Related]
5. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation.
Eckhardt K; Li S; Ammon S; Schänzle G; Mikus G; Eichelbaum M
Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456
[TBL] [Abstract][Full Text] [Related]
6. Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drugs-of-abuse testing.
Lafolie P; Beck O; Lin Z; Albertioni F; Boréus L
J Anal Toxicol; 1996; 20(7):541-6. PubMed ID: 8934303
[TBL] [Abstract][Full Text] [Related]
7. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6 ultrarapid metabolism and morphine/codeine ratios in blood: was it codeine or heroin?
He YJ; Brockmöller J; Schmidt H; Roots I; Kirchheiner J
J Anal Toxicol; 2008 Mar; 32(2):178-82. PubMed ID: 18334103
[TBL] [Abstract][Full Text] [Related]
9. Functional phenotyping of the CYP2D6 probe drug codeine in the horse.
Gretler SR; Finno CJ; Kass PH; Knych HK
BMC Vet Res; 2021 Feb; 17(1):77. PubMed ID: 33581736
[TBL] [Abstract][Full Text] [Related]
10. Investigation of morphine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths.
Frost J; Helland A; Nordrum IS; Slørdal L
Forensic Sci Int; 2012 Jul; 220(1-3):6-11. PubMed ID: 22285504
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses.
Gretler SR; Finno CJ; McKemie DS; Kass PH; Knych HK
Vet Anaesth Analg; 2020 Sep; 47(5):694-704. PubMed ID: 32654915
[TBL] [Abstract][Full Text] [Related]
12. Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry.
Bogusz MJ; Maier RD; Erkens M; Driessen S
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):115-27. PubMed ID: 9448068
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Zhou SF
Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
[TBL] [Abstract][Full Text] [Related]
14. A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC-MS.
Frost J; Løkken TN; Brede WR; Hegstad S; Nordrum IS; Slørdal L
J Anal Toxicol; 2015 Apr; 39(3):203-12. PubMed ID: 25556373
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 phenotype-specific codeine population pharmacokinetics.
Linares OA; Fudin J; Schiesser WE; Daly Linares AL; Boston RC
J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):4-15. PubMed ID: 25562725
[TBL] [Abstract][Full Text] [Related]
17. On the assessment of drug metabolism by assays of codeine and its main metabolites.
Haffen E; Paintaud G; Berard M; Masuyer C; Bechtel Y; Bechtel PR
Ther Drug Monit; 2000 Jun; 22(3):258-65. PubMed ID: 10850391
[TBL] [Abstract][Full Text] [Related]
18. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
Poulsen L; Brøsen K; Arendt-Nielsen L; Gram LF; Elbaek K; Sindrup SH
Eur J Clin Pharmacol; 1996; 51(3-4):289-95. PubMed ID: 9010701
[TBL] [Abstract][Full Text] [Related]
19. Codeine in post-operative pain. Study of the influence of sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide.
Poulsen L; Riishede L; Brøsen K; Clemensen S; Sindrup SH
Eur J Clin Pharmacol; 1998 Aug; 54(6):451-4. PubMed ID: 9776433
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF
Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
